Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases.
View Top Employees from Aspect BiosystemsWebsite | http://www.aspectbiosystems.com |
Revenue | $12 million |
Funding | $21 million |
Employees | 104 (93 on RocketReach) |
Founded | 2013 |
Address | 1781 W 75th Ave, Vancouver, British Columbia V6P 6P2, CA |
Phone | (604) 263-0502 |
Technologies |
JavaScript,
HTML,
Twitter
+38 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, 3D Printing, Business Services, Manufacturing, Biotechnology, Science and Engineering |
Web Rank | 4 Million |
Keywords | Aspect Biosystems, 3d Bioprinter, Aspect Byosistem, Mechatronic Engineer Canada, 3d Bioprinter In Europe |
Competitors | CELLINK, Organovo Holdings, Inc., Poietis, Solarvest BioEnergy, Think Tank L L C |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies |
Looking for a particular Aspect Biosystems employee's phone or email?
The Aspect Biosystems annual revenue was $12 million in 2024.
Simon Beyer is the CTO of Aspect Biosystems.
93 people are employed at Aspect Biosystems.
Aspect Biosystems is based in Vancouver, British Columbia.
The NAICS codes for Aspect Biosystems are [54, 541713, 541, 5417, 54171, 541714].
The SIC codes for Aspect Biosystems are [87, 873].